Ventricular Assist Devices Market Share Growth Report With, Medtronic, Abbott, Abiomed, Berlin Heart Inc, BiVACOR Inc, CardiacAssist, Inc., Evaheart, Inc., Terumo Medical Corporation, Maquet Getinge Group

U.S. dominated the North America ventricular assist devices market and was valued at around USD 615.1 million in the year 2017. According to Center for Disease Control and Prevention (CDC), around 610,000 people die of heart disease in the U.S. every year. Increase in number of people suffering from cardiovascular disease, recent technological advancements and favorable reimbursement policies in the country will boost the demand and adoption rate of ventricular assist devices, augmenting the market growth in United States.

India ventricular assist devices market is estimated to grow substantially at a CAGR of 15.2% during the projection period. Growing geriatric population in the Asia Pacific region will result in high cardiovascular disease prevalence leading to high heart failure rates. Also, rise in awareness among the patients about the treatments related to cardiovascular diseases and heart failure will increase the demand for ventricular assist devices in the country.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3014

The sales of ventricular assist devices among people aged between 60-79 years was high and was valued at around USD 444.0 million in the year 2017. According to a recent research survey, it was observed that the chances of heart failure are high, and prevalence of cardiovascular diseases is around 70% to 75% in people of 0-79 years of age. Increase in geriatric population across the globe will result in growing number of people prone to cardiovascular diseases, fuelling the growth of ventricular assist devices in the future.

The sales of the ventricular assist devices among people aged between 40-59 years is estimated to grow significantly at a CAGR of 10.6% over the forecast timeframe. As per the research studies, the prevalence of cardiovascular diseases among people aged between 40-59 years is around 40% but, growing sedentary lifestyle, smoking, alcohol consumption and improper eating habits is expected to increase the prevalence. Growing prevalence of cardiovascular disease in people aged between 40-59 years will boost the sales of ventricular assist devices.

Bridge-to-candidacy (BTC) therapy market held the maximum market share an was valued around at USD 316.4 million in the year 2017. Decrease in number of heart donors across the globe has resulted in people opting for ventricular assist devices, but the patients that are not listed for transplantation are provided BTC therapy. Increase in use of BTC therapy for severe heart failure patients needing ventricular assist device implantation urgently will enhance the market growth in the near future.


Browse Full Report Details @ https://www.gminsights.com/industry-analysis/ventricular-assist-devices-market

Destination therapy market is projected to witness considerable amount of growth at a CAGR of 10.8% during the forecast time period. Destination therapy provides long-term support to the patients and is one of the most advised therapies in the treatment of severe end-stage heart failure amongst the population. Several benefits provided such as high survival rate, better quality of life, cost-effectiveness and cost utility will be one of the major reasons for boosting the growth of ventricular assist devices market for destination therapy.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
 Abbott
 Abiomed
 Berlin Heart Inc
 BiVACOR Inc
 CardiacAssist, Inc.
 Evaheart, Inc.
 Maquet Getinge Group
 Medtronic, Terumo Medical Corporation

Increase in number of people suffering from heart failure and other cardiovascular diseases in European countries will be one of the major impact rendering factors for the growth of ventricular assist devices market in the forthcoming years. As per the statistics published by the European Heart Network, every year around 4 million people in Europe and over 2 million in Europe Union (EU) die because of several cardiovascular diseases. Increase in patients suffering from cardiovascular diseases leading to heart failure will lead to growing demand and adoption rate of ventricular assist devices, fueling the industry growth.

Technological advancements in the North America region has resulted in ventricular assist devices becoming an increasingly widespread and accepted therapy for patients suffering from high heart failure rate. Technological advances have led to improved durability of the devices’ implantability, extended support and also lengthened the survival rates in patients. Introduction of latest third generation left ventricular assist device employs magnetic levitation (MAGLEV) technology that allows rotation without wear and friction. Hence, growing technological advancements pertaining to ventricular assist devices in North America will boost the market growth.

High cost of the devices and the implantation procedures will be one of the major factors impeding the growth of the market. The ventricular assist device on an average costs around USD 100,000 and the total procedure costs around USD 700,000 over a six year period. The high cost of the device and procedures is unaffordable to the low and middle income patient population, thereby declining the demand and growth of the business.

Left ventricular assist devices market held the majority of market share in the year 2017 and was valued over USD 829.9 million. Increase in number of people suffering from end-stage heart failure will result in growing demand and adoption rate for LVAD devices, enhancing the left ventricular assist devices market growth in the near future.


Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3014

Right ventricular assist devices market is estimated to grow at a robust CAGR of 10.6% in the forthcoming years. Increase in number of people suffering from acute right ventricular failure will result in boosting the demand and adoption rate, thereby augmenting business growth in the near future.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: http://solutionrocket.com

This release was published on openPR.